NJ Bio, Inc. is excited to announce its participation in the BIO International Convention 2025, to be held from June 16-19, at the Boston Convention & Exhibition Center. It is one of the largest and most comprehensive events in the biotech industry, bringing together over 20,000 innovators, researchers, and industry leaders from around the world. This flagship event has been serving as a platform for building connections and creative collaborations in the biotechnology industry since the past 32 years. It features a diverse range of sessions and exhibits highlighting the latest research and advancements in the field. Additionally, Bio Partnering™, a proprietary SaaS platform developed and owned by BIO, forms the largest trade association for biotechnology in the world.
Experts from NJ Bio and Cohance, will be available at Booth Number 2287 to talk about how chemistry-driven innovation can help solve complex challenges and accelerate development of ADCs and nucleic acid-based therapeutics. The event presents an exciting chance for both teams to connect with fellow industry professionals, share insights, and establish new partnerships while also getting a chance to learn from leaders in the field. The team looks forward to the opportunities for collaboration and knowledge exchange at this global event.
Find out more about the BIO International Convention 2025 at https://convention.bio.org/bio-2025
————-For more news and events, click here